Products
ProStrakan markets a range of products in a number of key EU territories and the US. Our business model allows for revenues arising from product sales to be invested into our development operations where new medicines can be produced for the benefit of more and more patients in the future.
As ProStrakan has grown and evolved over the years, we have acquired and merged with a number of companies which has led to us selling a range of products, some of which lie beyond our prime therapeutic focus but are still providing help to many patients.
* Please note that the information provided is specific to residents of individual countries because each product may not be available in all countries in which we operate or the licensed prescribing information may differ from country to country.
